このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

BIO-key International マネジメント

マネジメント基準チェック /44

BIO-key International'sの CEO はMike DePasqualeで、 Jan2003年に任命され、の在任期間は 21.42年です。の年間総報酬は$ 291.53Kで、 93%給与と7%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.84%を直接所有しており、その価値は$ 22.86K 。経営陣と取締役会の平均在任期間はそれぞれ7.3年と7.2年です。

主要情報

Mike DePasquale

最高経営責任者

US$291.5k

報酬総額

CEO給与比率	93.0%
CEO在任期間	21.5yrs
CEOの所有権	0.8%
経営陣の平均在職期間	7.4yrs
取締役会の平均在任期間	7.3yrs

経営陣の近況

Recent updates

BIO-key GAAP EPS of -$0.21, revenue of $1.9M

Aug 12

Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

Jun 12

BIO-key International, Inc.'s (NASDAQ:BKYI) Shift From Loss To Profit

Feb 28

BIO-key International climbs 4% backed by PortalGuard Solution for US Department of Justice

Jan 06

CEO報酬分析

BIO-key International の収益と比較して、Mike DePasquale の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	-US$7m
Dec 31 2023	US$292k	US$271k	-US$9m
Sep 30 2023	n/a	n/a	-US$11m
Jun 30 2023	n/a	n/a	-US$12m
Mar 31 2023	n/a	n/a	-US$13m
Dec 31 2022	US$372k	US$296k	-US$12m
Sep 30 2022	n/a	n/a	-US$7m
Jun 30 2022	n/a	n/a	-US$6m
Mar 31 2022	n/a	n/a	-US$5m
Dec 31 2021	US$277k	US$275k	-US$5m
Sep 30 2021	n/a	n/a	-US$4m
Jun 30 2021	n/a	n/a	-US$7m
Mar 31 2021	n/a	n/a	-US$7m
Dec 31 2020	US$349k	US$275k	-US$10m
Sep 30 2020	n/a	n/a	-US$18m
Jun 30 2020	n/a	n/a	-US$16m
Mar 31 2020	n/a	n/a	-US$16m
Dec 31 2019	US$311k	US$275k	-US$15m
Sep 30 2019	n/a	n/a	-US$6m
Jun 30 2019	n/a	n/a	-US$8m
Mar 31 2019	n/a	n/a	-US$8m
Dec 31 2018	US$333k	US$275k	-US$8m
Sep 30 2018	n/a	n/a	-US$7m
Jun 30 2018	n/a	n/a	-US$6m
Mar 31 2018	n/a	n/a	-US$6m
Dec 31 2017	US$843k	US$250k	-US$5m

報酬と市場: Mikeの総報酬 ($USD 291.53K ) は、 US市場 ($USD 673.68K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Mikeの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Mike DePasquale (69 yo)

21.5yrs

在職期間

US$291,527

報酬

Mr. Michael W. DePasquale, also known as Mike, has been the Chief Executive Officer of BIO-key International Inc. since January 3, 2003. He has been the Chairman and Director of BIO-key International Inc....

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Michael DePasquale	Chairman & CEO	21.5yrs	US$291.53k	0.84% $ 25.0k
Cecilia Welch	Chief Financial Officer	14.6yrs	US$207.70k	0.10% $ 3.1k
James Sullivan	Senior VP of Strategy & Compliance and Chief Legal Officer	4.4yrs	US$235.41k	1.21% $ 36.0k
Mira LaCous	Chief Technology Officer	10.3yrs	US$240.43k	0.074% $ 2.2k
Akintunde Jeje	Managing Director of Africa	4.5yrs	データなし	データなし
Alex Rocha	Managing Director of EMEA	2.2yrs	データなし	データなし
Mark Cochran	President of PortalGuard	no data	データなし	データなし

7.4yrs

平均在職期間

63yo

平均年齢

経験豊富な経営陣: BKYIの経営陣は経験豊富で経験豊富です（平均在職期間は7.3年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Michael DePasquale	Chairman & CEO	21.5yrs	US$291.53k	0.84% $ 25.0k
Cameron Williams	Independent Director	1.1yrs	US$4.00k	0.034% $ 1.0k
Robert Michel	Independent Director	7.3yrs	US$11.00k	0.10% $ 3.0k
Kwok Fong Wong	Vice-Chairman of the Board	8.6yrs	データなし	1.71% $ 50.8k
Emmanuel Alia	Independent Director	4.3yrs	US$10.00k	0.11% $ 3.2k

7.3yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: BKYIの取締役会は経験豊富であると考えられます ( 7.2年の平均在任期間)。

BIO-key International マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

BIO-key International, Inc. Announces Resignation of Thomas E. Bush, III From the Board of Directors

BIO-key International, Inc., Annual General Meeting, Jul 24, 2023

Bio-Key International, Inc. Appoints Cameron E. Williams to Its Board of Directors

Insufficient new directors

BIO-key International, Inc. Announces Thomas Gilley to Resign from the Board of Directors

Bio-Key International, Inc Announces Anticipation of the Planned Retirement of Fred Corsentino, Chief Revenue Officer

Recent updates

BIO-key International, Inc. Receives Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(b)(1)

BIO-key International, Inc. announced delayed 10-Q filing

BIO-key International, Inc. announced delayed annual 10-K filing

BIO-key International, Inc. to Report Q4, 2023 Results on Apr 02, 2024

Forecast to breakeven in 2024

BIO-key International, Inc. announced that it has received $0.547726 million in funding from Dillon Hill Capital, LLC

BIO-key International, Inc. announced delayed 10-Q filing

BIO-key International, Inc. Announces Resignation of Thomas E. Bush, III From the Board of Directors

Price target decreased by 25% to US$1.50

BIO-key International, Inc. has completed a Composite Units Offering in the amount of $3.75025 million.

BIO-key International, Inc. announced delayed 10-Q filing

Price target decreased by 60% to US$2.00

BIO-key International, Inc. to Report Q2, 2023 Results on Aug 14, 2023

BIO-Key International Receives a Letter from Nasdaq

BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its First Quarter 2023 Form 10-Q with SEC

BIO-key International, Inc., Annual General Meeting, Jul 24, 2023

Bio-Key International, Inc. Appoints Cameron E. Williams to Its Board of Directors

BIO-key International Receives Notice of Non-Compliance from Nasdaq

BIO-key International, Inc. announced delayed 10-Q filing

First quarter 2023 earnings released: US$0.057 loss per share (vs US$0.13 loss in 1Q 2022)

BIO-key International, Inc. to Report Q1, 2023 Results on May 15, 2023

Insufficient new directors

BIO-key International, Inc. Announces Thomas Gilley to Resign from the Board of Directors

BIO-key Receives Nasdaq Notification Regarding $1.00 Minimum Closing Bid Price Requirement

Bio-Key International, Inc Announces Anticipation of the Planned Retirement of Fred Corsentino, Chief Revenue Officer

BIO-key International, Inc. announced that it has received $2.2 million in funding from AJB Investment Management, LLC

Price target decreased to US$4.00

Insufficient new directors

BIO-Key International, Inc. Provides Revenue Guidance for the Year 2022

BIO-key International, Inc. to Report Q3, 2022 Results on Nov 14, 2022

BIO-key International, Inc. Showcases PortalGuard Identity and Access Management Platform for Higher Education at EDUCAUSE Annual Conference October 25-28

BIO-key International, Inc. Launches Mobile Authenticator with Server-Secured and On-Device Multi-Biometric Methods to Be Showcased At 2022 Gartner IAM Summit

BIO-key International, Inc. announced delayed 10-Q filing

Insufficient new directors

BIO-key International, Inc. Provides Financial Guidance for Full-Year 2022

BIO-key GAAP EPS of -$0.21, revenue of $1.9M

BIO-key International, Inc. to Report Q2, 2022 Results on Aug 12, 2022

BIO-key Showcases Biometric Cybersecurity Solutions at MSP Expo Florida (Booth 536) to Support its Growing Distribution Base of Managed Service Providers

BIO-key International, Inc. announced delayed 10-Q filing

BIO-key International, Inc. to Report Q1, 2022 Results on May 16, 2022

BIO-key International, Inc., Annual General Meeting, Jun 24, 2022

BIO-key International, Inc. announced delayed annual 10-K filing

Bio-Key International, Inc. Provides Earnings Guidance for the Full Year 2022

Full year 2021 earnings released: US$0.65 loss per share (vs US$2.08 loss in FY 2020)

BIO-key International, Inc. (NasdaqCM:BKYI) signed a definitive agreement to acquire Swivel Secure Europe, S.A.

Bio-Key International, Inc. Launches Enhanced Admin Panel and User Experience for IT Teams Managing Its Portalguard Identity-As-A-Service (IDaaS) Solution

Insufficient new directors

No longer forecast to breakeven

Third quarter 2021 earnings released: US$0.13 loss per share (vs US$0.51 loss in 3Q 2020)

BIO-key International, Inc Expands Product Line and Market Reach with Launch of FIDO2 Compliant Security Keys in a Variety of Form Factors

Forecast to breakeven in 2022

BIO-key International, Inc. Announces Improved Next-Generation EcoID II USB Compact Fingerprint Scanner

BIO-Key International, Inc. Confirms Revenue Guidance for the Full Year 2021

Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.60 loss in 2Q 2020)

Bio-Key Introduces SSO Concierge™ to Its Portalguard Identity & Access Management Platform, Eliminating Passwords for Thick Client Applications

Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

First quarter 2021 earnings released: US$0.094 loss per share (vs US$1.84 loss in 1Q 2020)

BIO-key International, Inc Provides Earnings Guidance for the Year 2021

BIO-Key International, Inc. Introduces BIO-key MobileAuth

BIO-key International, Inc. Provides Earnings Guidance for the Fiscal 2021

Full year 2020 earnings released: US$2.08 loss per share (vs US$8.10 loss in FY 2019)

BIO-key International, Inc. to Report Fiscal Year 2020 Results on Mar 25, 2021

BIO-key International, Inc.'s (NASDAQ:BKYI) Shift From Loss To Profit

West Coast State Election Office Expands Bio-Key International, Inc.'s Biometric Multi-Factor Authentication Solution

BIO-key International, Inc. Announces Partnership With Appsian to Provide Advanced Authentication Security to Enterprise Resource Planning (ERP) Applications

New 90-day high: US$4.51

Bio-Key International, Inc. Announces New Capabilities for Its Portalguard IDaaS Cloud-Delivered Authentication Solution

Southeastern Illinois College Selects BIO-key International, Inc.'s Cloud-Based PortalGuard Identity-as-a-Service Platform for Enhanced Secure Access to Critical Applications

New 90-day high: US$3.98

マネジメント基準チェック /44